-
1
-
-
84858702540
-
The worldwide epidemiology of type 2 diabetes mellitus - Present and future perspectives
-
Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus - present and future perspectives. Nat Rev Endocrinol 2012;8:228-236
-
(2012)
Nat Rev Endocrinol
, vol.8
, pp. 228-236
-
-
Chen, L.1
Magliano, D.J.2
Zimmet, P.Z.3
-
2
-
-
84858383401
-
Diabetes mellitus and the β cell: The last ten years
-
Ashcroft FM, Rorsman P. Diabetes mellitus and the β cell: the last ten years. Cell 2012;148:1160-1171
-
(2012)
Cell
, vol.148
, pp. 1160-1171
-
-
Ashcroft, F.M.1
Rorsman, P.2
-
3
-
-
33745863033
-
Islet beta cell failure in type 2 diabetes
-
Prentki M, Nolan CJ. Islet beta cell failure in type 2 diabetes. J Clin Invest 2006;116:1802-1812
-
(2006)
J Clin Invest
, vol.116
, pp. 1802-1812
-
-
Prentki, M.1
Nolan, C.J.2
-
4
-
-
33644747390
-
Mechanisms of beta-cell death in type 2 diabetes
-
Donath MY, Ehses JA, Maedler K, et al. Mechanisms of beta-cell death in type 2 diabetes. Diabetes 2005;54(Suppl. 2):S108-S113
-
(2005)
Diabetes
, vol.54
, Issue.SUPPL. 2
-
-
Donath, M.Y.1
Ehses, J.A.2
Maedler, K.3
-
5
-
-
84856696054
-
Plasma deoxysphingolipids: A novel class of biomarkers for the metabolic syndrome?
-
Othman A, Rütti MF, Ernst D, et al. Plasma deoxysphingolipids: a novel class of biomarkers for the metabolic syndrome? Diabetologia 2012;55:421-431
-
(2012)
Diabetologia
, vol.55
, pp. 421-431
-
-
Othman, A.1
Rütti, M.F.2
Ernst, D.3
-
6
-
-
77955526888
-
Deoxysphingoid bases as plasma markers in diabetes mellitus
-
Bertea M, Rütti MF, Othman A, et al. Deoxysphingoid bases as plasma markers in diabetes mellitus. Lipids Health Dis 2010;9:84
-
(2010)
Lipids Health Dis
, vol.9
, pp. 84
-
-
Bertea, M.1
Rütti, M.F.2
Othman, A.3
-
7
-
-
0034725101
-
The marine compound spisulosine, an inhibitor of cell proliferation, promotes the disassembly of actin stress fibers
-
Cuadros R, Montejo de Garcini E, Wandosell F, Faircloth G, Fernández-Sousa JM, Avila J. The marine compound spisulosine, an inhibitor of cell proliferation, promotes the disassembly of actin stress fibers. Cancer Lett 2000;152:23-29
-
(2000)
Cancer Lett
, vol.152
, pp. 23-29
-
-
Cuadros, R.1
Montejo De Garcini, E.2
Wandosell, F.3
Faircloth, G.4
Fernández-Sousa, J.M.5
Avila, J.6
-
8
-
-
33846514589
-
The marine sphingolipid-derived compound ES 285 triggers an atypical cell death pathway
-
Salcedo M, Cuevas C, Alonso JL, et al. The marine sphingolipid-derived compound ES 285 triggers an atypical cell death pathway. Apoptosis 2007;12:395-409
-
(2007)
Apoptosis
, vol.12
, pp. 395-409
-
-
Salcedo, M.1
Cuevas, C.2
Alonso, J.L.3
-
9
-
-
41249098642
-
Spisulosine (ES-285) induces prostate tumor PC-3 and LNCaP cell death by de novo synthesis of ceramide and PKCzeta activation
-
Sánchez AM, Malagarie-Cazenave S, Olea N, Vara D, Cuevas C, Díaz-Laviada I. Spisulosine (ES-285) induces prostate tumor PC-3 and LNCaP cell death by de novo synthesis of ceramide and PKCzeta activation. Eur J Pharmacol 2008;584:237-245
-
(2008)
Eur J Pharmacol
, vol.584
, pp. 237-245
-
-
Sánchez, A.M.1
Malagarie-Cazenave, S.2
Olea, N.3
Vara, D.4
Cuevas, C.5
Díaz-Laviada, I.6
-
10
-
-
77951218516
-
Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids
-
Penno A, Reilly MM, Houlden H, et al. Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids. J Biol Chem 2010;285:11178-11187
-
(2010)
J Biol Chem
, vol.285
, pp. 11178-11187
-
-
Penno, A.1
Reilly, M.M.2
Houlden, H.3
-
11
-
-
0026550830
-
Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines
-
Asfari M, Janjic D, Meda P, Li G, Halban PA, Wollheim CB. Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. Endocrinology 1992;130:167-178
-
(1992)
Endocrinology
, vol.130
, pp. 167-178
-
-
Asfari, M.1
Janjic, D.2
Meda, P.3
Li, G.4
Halban, P.A.5
Wollheim, C.B.6
-
12
-
-
0034006587
-
Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion
-
Hohmeier HE, Mulder H, Chen G, Henkel-Rieger R, Prentki M, Newgard CB. Isolation of INS-1-derived cell lines with robust ATP-sensitive K+ channel-dependent and -independent glucose-stimulated insulin secretion. Diabetes 2000;49:424-430
-
(2000)
Diabetes
, vol.49
, pp. 424-430
-
-
Hohmeier, H.E.1
Mulder, H.2
Chen, G.3
Henkel-Rieger, R.4
Prentki, M.5
Newgard, C.B.6
-
13
-
-
34547596343
-
Rat pancreatic islet size standardization by the "hanging drop" technique
-
Cavallari G, Zuellig RA, Lehmann R, Weber M, Moritz W. Rat pancreatic islet size standardization by the "hanging drop" technique. Transplant Proc 2007;39:2018-2020
-
Transplant Proc 2007
, vol.39
, pp. 2018-2020
-
-
Cavallari, G.1
Zuellig, R.A.2
Lehmann, R.3
Weber, M.4
Moritz, W.5
-
15
-
-
79952282238
-
Cdk5 interacts with Hif-1α in neurons: A new hypoxic signalling mechanism?
-
Antoniou X, Gassmann M, Ogunshola OO. Cdk5 interacts with Hif-1α in neurons: a new hypoxic signalling mechanism? Brain Res 2011;1381:1-10
-
(2011)
Brain Res
, vol.1381
, pp. 1-10
-
-
Antoniou, X.1
Gassmann, M.2
Ogunshola, O.O.3
-
16
-
-
79951912532
-
Four faces of cellular senescence
-
Rodier F, Campisi J. Four faces of cellular senescence. J Cell Biol 2011;192:547-556
-
(2011)
J Cell Biol
, vol.192
, pp. 547-556
-
-
Rodier, F.1
Campisi, J.2
-
17
-
-
84864572894
-
Cyclin-dependent kinase inhibitor p21(Waf1): Contemporary view on its role in senescence and oncogenesis
-
Mosc
-
Romanov VS, Pospelov VA, Pospelova TV. Cyclin-dependent kinase inhibitor p21(Waf1): contemporary view on its role in senescence and oncogenesis. Biochemistry (Mosc) 2012;77:575-584
-
(2012)
Biochemistry
, vol.77
, pp. 575-584
-
-
Romanov, V.S.1
Pospelov, V.A.2
Pospelova, T.V.3
-
18
-
-
84878679199
-
A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence
-
Kaplon J, Zheng L, Meissl K, et al. A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence. Nature 2013;498:109-112
-
(2013)
Nature
, vol.498
, pp. 109-112
-
-
Kaplon, J.1
Zheng, L.2
Meissl, K.3
-
19
-
-
77951727293
-
Lipids on trial: The search for the offending metabolite in Niemann-Pick type C disease
-
Lloyd-Evans E, Platt FM. Lipids on trial: the search for the offending metabolite in Niemann-Pick type C disease. Traffic 2010;11:419-428
-
(2010)
Traffic
, vol.11
, pp. 419-428
-
-
Lloyd-Evans, E.1
Platt, F.M.2
-
20
-
-
2942665893
-
Cellular pathology of Niemann-Pick type C disease
-
Ikonen E, Hölttä-Vuori M. Cellular pathology of Niemann-Pick type C disease. Semin Cell Dev Biol 2004;15:445-454
-
(2004)
Semin Cell Dev Biol
, vol.15
, pp. 445-454
-
-
Ikonen, E.1
Hölttä-Vuori, M.2
-
21
-
-
50149083752
-
Mammalian Rho GTPases: New insights into their functions from in vivo studies
-
Heasman SJ, Ridley AJ. Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat Rev Mol Cell Biol 2008;9:690-701
-
(2008)
Nat Rev Mol Cell Biol
, vol.9
, pp. 690-701
-
-
Heasman, S.J.1
Ridley, A.J.2
-
22
-
-
0015058101
-
Insulin resistance in genetically obese, hyperglycemic mice
-
Genuth SM, Przybylski RJ, Rosenberg DM. Insulin resistance in genetically obese, hyperglycemic mice. Endocrinology 1971;88:1230-1238
-
(1971)
Endocrinology
, vol.88
, pp. 1230-1238
-
-
Genuth, S.M.1
Przybylski, R.J.2
Rosenberg, D.M.3
-
23
-
-
0141780910
-
Extensive islet amyloid formation is induced by development of type II diabetes mellitus and contributes to its progression: Pathogenesis of diabetes in a mouse model
-
Höppener JW, Oosterwijk C, Nieuwenhuis MG, et al. Extensive islet amyloid formation is induced by development of type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model. Diabetologia 1999;42:427-434
-
(1999)
Diabetologia
, vol.42
, pp. 427-434
-
-
Höppener, J.W.1
Oosterwijk, C.2
Nieuwenhuis, M.G.3
-
24
-
-
0041887212
-
Glucose regulates the cortical actin network through modulation of Cdc42 cycling to stimulate insulin secretion
-
Nevins AK, Thurmond DC. Glucose regulates the cortical actin network through modulation of Cdc42 cycling to stimulate insulin secretion. Am J Physiol Cell Physiol 2003;285:C698-C710
-
(2003)
Am J Physiol Cell Physiol
, vol.285
-
-
Nevins, A.K.1
Thurmond, D.C.2
-
25
-
-
33745201223
-
Regulation of pancreatic beta-cell insulin secretion by actin cytoskeleton remodelling: Role of gelsolin and cooperation with the MAPK signalling pathway
-
Tomas A, Yermen B, Min L, Pessin JE, Halban PA. Regulation of pancreatic beta-cell insulin secretion by actin cytoskeleton remodelling: role of gelsolin and cooperation with the MAPK signalling pathway. J Cell Sci 2006;119:2156-2167
-
(2006)
J Cell Sci
, vol.119
, pp. 2156-2167
-
-
Tomas, A.1
Yermen, B.2
Min, L.3
Pessin, J.E.4
Halban, P.A.5
-
26
-
-
0018755463
-
Interaction between insulin-storage granules and F-actin in vitro
-
Howell SL, Tyhurst M. Interaction between insulin-storage granules and F-actin in vitro. Biochem J 1979;178:367-371
-
(1979)
Biochem J
, vol.178
, pp. 367-371
-
-
Howell, S.L.1
Tyhurst, M.2
-
27
-
-
33845336495
-
Ceramides and other bioactive sphingolipid backbones in health and disease: Lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy
-
Zheng W, Kollmeyer J, Symolon H, et al. Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy. Biochim Biophys Acta 2006;1758:1864-1884
-
(2006)
Biochim Biophys Acta
, vol.1758
, pp. 1864-1884
-
-
Zheng, W.1
Kollmeyer, J.2
Symolon, H.3
-
28
-
-
0029059122
-
Ceramide inhibits pancreatic beta-cell insulin production and mitogenesis and mimics the actions of interleukin-1 beta
-
Sjöholm A. Ceramide inhibits pancreatic beta-cell insulin production and mitogenesis and mimics the actions of interleukin-1 beta. FEBS Lett 1995;367:283-286
-
(1995)
FEBS Lett
, vol.367
, pp. 283-286
-
-
Sjöholm, A.1
-
29
-
-
0042531617
-
Palmitate inhibition of insulin gene expression is mediated at the transcriptional level via ceramide synthesis
-
Kelpe CL, Moore PC, Parazzoli SD, Wicksteed B, Rhodes CJ, Poitout V. Palmitate inhibition of insulin gene expression is mediated at the transcriptional level via ceramide synthesis. J Biol Chem 2003;278:30015-30021
-
(2003)
J Biol Chem
, vol.278
, pp. 30015-30021
-
-
Kelpe, C.L.1
Moore, P.C.2
Parazzoli, S.D.3
Wicksteed, B.4
Rhodes, C.J.5
Poitout, V.6
-
30
-
-
80051757598
-
Ceramide formation as a target in beta-cell survival and function
-
Lang F, Ullrich S, Gulbins E. Ceramide formation as a target in beta-cell survival and function. Expert Opin Ther Targets 2011;15:1061-1071
-
(2011)
Expert Opin Ther Targets
, vol.15
, pp. 1061-1071
-
-
Lang, F.1
Ullrich, S.2
Gulbins, E.3
-
31
-
-
79960814460
-
Ceramide synthase 4 and de novo production of ceramides with specific N-acyl chain lengths are involved in glucolipotoxicity-induced apoptosis of INS-1 β-cells
-
Véret J, Coant N, Berdyshev EV, et al. Ceramide synthase 4 and de novo production of ceramides with specific N-acyl chain lengths are involved in glucolipotoxicity-induced apoptosis of INS-1 β-cells. Biochem J 2011;438:177-189
-
(2011)
Biochem J
, vol.438
, pp. 177-189
-
-
Véret, J.1
Coant, N.2
Berdyshev, E.V.3
-
32
-
-
23244447037
-
BRAFE600-associated senescence-like cell cycle arrest of human naevi
-
Michaloglou C, Vredeveld LC, Soengas MS, et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 2005;436:720-724
-
(2005)
Nature
, vol.436
, pp. 720-724
-
-
Michaloglou, C.1
Vredeveld, L.C.2
Soengas, M.S.3
-
33
-
-
23244461708
-
Oncogene-induced senescence as an initial barrier in lymphoma development
-
Braig M, Lee S, Loddenkemper C, et al. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 2005;436:660-665
-
(2005)
Nature
, vol.436
, pp. 660-665
-
-
Braig, M.1
Lee, S.2
Loddenkemper, C.3
-
34
-
-
72949096792
-
Senescence in tumours: Evidence from mice and humans
-
Collado M, Serrano M. Senescence in tumours: evidence from mice and humans. Nat Rev Cancer 2010;10:51-57
-
(2010)
Nat Rev Cancer
, vol.10
, pp. 51-57
-
-
Collado, M.1
Serrano, M.2
-
35
-
-
0037401894
-
Intracellular signal transduction pathways activated by ceramide and its metabolites
-
Ruvolo PP. Intracellular signal transduction pathways activated by ceramide and its metabolites. Pharmacol Res 2003;47:383-392
-
(2003)
Pharmacol Res
, vol.47
, pp. 383-392
-
-
Ruvolo, P.P.1
-
36
-
-
78650917095
-
p38 MAPK and JNK antagonistically control senescence and cytoplasmic p16INK4A expression in doxorubicin-treated endothelial progenitor cells
-
Spallarossa P, Altieri P, Barisione C, et al. p38 MAPK and JNK antagonistically control senescence and cytoplasmic p16INK4A expression in doxorubicin-treated endothelial progenitor cells. PLoS ONE 2010;5:e15583
-
(2010)
PLoS ONE
, vol.5
-
-
Spallarossa, P.1
Altieri, P.2
Barisione, C.3
-
37
-
-
0036315888
-
Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: Evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated
-
Lupi R, Dotta F, Marselli L, et al. Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. Diabetes 2002;51:1437-1442
-
(2002)
Diabetes
, vol.51
, pp. 1437-1442
-
-
Lupi, R.1
Dotta, F.2
Marselli, L.3
-
38
-
-
84861910718
-
A role for aberrant protein palmitoylation in FFA-induced ER stress and β-cell death
-
Baldwin AC, Green CD, Olson LK, Moxley MA, Corbett JA. A role for aberrant protein palmitoylation in FFA-induced ER stress and β-cell death. Am J Physiol Endocrinol Metab 2012;302:E1390-E1398
-
(2012)
Am J Physiol Endocrinol Metab
, vol.302
-
-
Baldwin, A.C.1
Green, C.D.2
Olson, L.K.3
Moxley, M.A.4
Corbett, J.A.5
-
39
-
-
0037219411
-
Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes
-
Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003;52:102-110
-
(2003)
Diabetes
, vol.52
, pp. 102-110
-
-
Butler, A.E.1
Janson, J.2
Bonner-Weir, S.3
Ritzel, R.4
Rizza, R.A.5
Butler, P.C.6
|